Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.95 CHF | +4.04% | -9.62% | +40.40% |
Apr. 17 | Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member | CI |
Mar. 19 | Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Newron Pharmaceuticals S.p.A.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- NWRN Stock
- Consensus Newron Pharmaceuticals S.p.A.